BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:WBC100 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of WBC100\, from ClinicalTrials.gov estimate
 s.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07014449-2891@assetmemo.bio
DTSTAMP:20261121T005631Z
DTSTART;VALUE=DATE:20261231
DTEND;VALUE=DATE:20270101
SUMMARY:WBC100: Phase 1 readout est. (NCT07014449)
DESCRIPTION:WBC100\, phase 1\, Acute Myeloid Leukemia.\nStudy: Clinical Tri
 al of WBC100 Capsule in Relapsed/Refractory Acute Myeloid Leukemia\nEstima
 ted primary completion: December 2026. This is a ClinicalTrials.gov estima
 te\, not a confirmed readout date\, and it can move.\nDrug page: https://a
 ssetmemo.bio/drug/wbc100#upcoming-events\nRegistry record: https://clinica
 ltrials.gov/study/NCT07014449
URL:https://assetmemo.bio/drug/wbc100#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
